Flow Diverter Stent for Endovascular Treatment of Unruptured Saccular Wide-necked Intracranial Aneurysms
EVIDENCE
Multicenter Randomized Study for Medico-economic Evaluation of Embolization With Flow Diverter Stent in the Endovascular Treatment of Unruptured Saccular Wide-necked Intracranial Aneurysms
2 other identifiers
interventional
91
1 country
1
Brief Summary
Unruptured saccular intracranial aneurysms larger than 7 mm can be treated with endovascular occlusion using detachable coils, with or without expendable stent assistance. A new endovascular technique has recently been developed, using flow diverter stents without associated coils. Clinical results already published are encouraging but have to be confirmed. Furthermore, these medical devices are expensive in comparison to the coiling strategy. The purpose of this study is to compare the clinical efficacy, safety, and cost-effectiveness of endovascular coiling and endovascular flow diversion for unrupted saccular intracranial aneurysms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2012
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2012
CompletedFirst Submitted
Initial submission to the registry
November 20, 2012
CompletedFirst Posted
Study publicly available on registry
March 14, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2020
CompletedDecember 19, 2025
December 1, 2025
3 years
November 20, 2012
December 13, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percentage of patients with complete occlusion of the treated aneurysm, defined as the absence of visible blood flow on angiography performed 12 months after endovascular procedure.
12 months
Secondary Outcomes (17)
Occurrence of a death during or after endovascular procedure
hospitalization for the endovascular procedure, up to 7 days
Occurrence of a death whatever the cause
24 months
Occurrence of a death due to aneurysm rupture
24 months
Occurrence of an intracranial hemorrhagic from rupture of the aneurysm
24 months
Occurrence of an ischemic stroke due to thrombosis
24 months
- +12 more secondary outcomes
Study Arms (2)
PIPELINE flow diverter stent
EXPERIMENTALflow diverter stent
Coils, with or without expendable stent
ACTIVE COMPARATORCoils
Interventions
endovascular embolization procedure using microspires, with the possibility of using a balloon temporary and / or implantation of a stent complementary intracranial before implementation of microspires
endovascular procedure using the medical device PIPELINE
Eligibility Criteria
You may qualify if:
- Patient's age ≥ 18 years old
- Unruptured saccular intracranial aneurysm diagnosed by angiography or CT angiography or MR angiography, located in the intra-dural area, with a neck diameter between 4 and 10 mm, with a sac diameter between 7 mm and 20 mm, with a ratio "dome/nek" greater than 1, and with a diameter of the parent artery between 2 and 5 mm.
- No prior treatment of the aneurysm
- Agreement for participating in the study and informed consent signed by the patient
- Patient affiliated to a social security scheme
You may not qualify if:
- Patient's age \< 18 years old
- Adult patient protected by law
- Contraindications to the endovascular procedure
- Contraindications to antiplatelet or anticoagulant treatment
- Prior treatment of the aneurysm
- Presence of an arteriovenous malformation
- Extradural location of the aneurysm
- Fusiform aneurysm
- Active bacterial infection (clinical signs)
- Intracranial hemorrhage from aneurysm in the previous month
- Pregnant or breastfeeding woman
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospices Civils de Lyon
Lyon, BRON, France
Related Publications (1)
Turjman F, Levrier O, Combaz X, Bonafe A, Biondi A, Desal H, Bracard S, Mounayer C, Riva R, Chapuis F, Huot L, Armoiry X, Gory B. EVIDENCE trial: design of a phase 2, randomized, controlled, multicenter study comparing flow diversion and traditional endovascular strategy in unruptured saccular wide-necked intracranial aneurysms. Neuroradiology. 2015 Jan;57(1):49-54. doi: 10.1007/s00234-014-1439-7. Epub 2014 Oct 4.
PMID: 25280445RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Francis TURJMAN, PH
Hospices Civils de Lyon
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 20, 2012
First Posted
March 14, 2013
Study Start
November 1, 2012
Primary Completion
November 1, 2015
Study Completion
March 1, 2020
Last Updated
December 19, 2025
Record last verified: 2025-12